PafosPharma, LLC is a pioneering pharmaceutical company based in Burlington, MA, dedicated to developing innovative cannabinoid therapies for various medical conditions, including ulcerative colitis, addiction, PTSD, neuropathic pain, and inflammatory response. With a focus on reducing inflammation, controlling symptoms, and inducing remission, PafosPharma aims to provide best-in-class therapeutics that address unmet medical needs and improve patients' quality of life.
Founded by Alexandros Makriyannis, PafosPharma collaborates closely with its sister company, MAKScientific, leveraging cutting-edge research and proprietary technologies to advance the field of cannabinoid medicine. With a commitment to scientific excellence and patient well-being, PafosPharma is at the forefront of developing medications that have the potential to revolutionize treatment options and make a positive impact on society.
Generated from the website